Geron Corp. said Thursday its board of directors has named John Scarlett as its new chief executive officer and to its board of directors.
Scarlett was previously the CEO of biotechnology Proteolix, which was acquired by Onyx Pharmaceuticals in November 2009 for $276 million.
No comments:
Post a Comment